BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37506530)

  • 1. Molecular subtyping and immune score system by a novel pyroptosis-based gene signature precisely predict immune infiltrating, survival and response to immune-checkpoint blockade in breast cancer.
    Zeng X; Huang X; Yin L; Yu H; Wang S; Li L
    Cancer Genet; 2023 Aug; 276-277():60-69. PubMed ID: 37506530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.
    Wang S; Gao S; Shan L; Qian X; Luan J; Lv X
    PeerJ; 2023; 11():e14691. PubMed ID: 36650832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
    Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
    World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyroptosis-related molecular classification and immune microenvironment infiltration in breast cancer: A novel therapeutic target.
    Luo J; Lai J
    J Cell Mol Med; 2022 Apr; 26(8):2259-2272. PubMed ID: 35233921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Breast Cancer.
    Wu J; Zhu Y; Luo M; Li L
    Front Immunol; 2021; 12():748221. PubMed ID: 34659246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation.
    Gong M; Liu X; Zhao X; Wang H
    BMC Cancer; 2022 Sep; 22(1):1005. PubMed ID: 36138348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes.
    Deng X; Wang Z; Luo Y; Li Z; Chen L
    Medicine (Baltimore); 2022 Sep; 101(37):e30304. PubMed ID: 36123889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
    He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C
    Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma.
    Yu H; Gong M; Qi J; Zhao C; Niu W; Sun S; Li S; Hong B; Qian J; Wang H; Chen X; Fang Z
    BMC Cancer; 2022 Aug; 22(1):885. PubMed ID: 35964070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A risk model based on pyroptosis subtypes predicts tumor immune microenvironment and guides chemotherapy and immunotherapy in bladder cancer.
    Wu T; Li S; Yu C; Wu Y; Long H
    Sci Rep; 2022 Dec; 12(1):21467. PubMed ID: 36509838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel pyroptosis-regulated gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma.
    Zhang B; Wang Z
    Front Mol Biosci; 2022; 9():890215. PubMed ID: 36262473
    [No Abstract]   [Full Text] [Related]  

  • 13. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
    Song S; Zhang M; Xie P; Wang S; Wang Y
    Front Immunol; 2022; 13():978909. PubMed ID: 36341328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of a Gene Signature for Lower-Grade Gliomas Based on Pyroptosis-Related Genes to Predict Survival and Response to Immune Checkpoint Inhibitors.
    Lai G; Li K; Deng J; Liu H; Xie B; Zhong X
    J Healthc Eng; 2022; 2022():8704127. PubMed ID: 35535221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel defined pyroptosis-related gene signature predicts prognosis and correlates with the tumour immune microenvironment in lung adenocarcinoma.
    Chen Z; Ge L; Xu S; Li Q; Zhou L
    Sci Rep; 2023 Jun; 13(1):9921. PubMed ID: 37337018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
    Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
    Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of pyroptosis related subtypes and tumor microenvironment infiltration characteristics in breast cancer.
    Huang G; Zhou J; Chen J; Liu G
    Sci Rep; 2022 Jun; 12(1):10640. PubMed ID: 35739182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
    Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
    BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    Front Immunol; 2021; 12():736030. PubMed ID: 34659224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of pyroptosis-related genes are correlated with immune microenvironment and predict prognosis in ESCA.
    Shi Y; Yang Q; Tai G; Chen X
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10701-10713. PubMed ID: 37302999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.